Media Partners

 

Scrip

We are pleased to support ERBI’s BioPartnering Exchange, and to mark the launch of Scrip’s BioPartnering Magazine. Scrip has been the world’s leading provider of biopharma news for 30+ years. Today, collaboration is arguably the lifeblood of our industry. Yet the growth of partnering has created unique challenges for businesses in this field. It is crucial that they keep up to speed with the opportunities, and that they are aware of the pitfalls. And they must know how the events and trends in this arena should shape their future partnering strategies. At Scrip, we recognised our readers’ need for this information. Enter Scrip’s BioPartnering Magazine…Written by experts in the field, and Scrip’s esteemed team, and always focused on the hottest topics of the moment – from alliance management and deal valuation through to getting the most from your licensing strategy – the publication has already attracted expert contributions from key industry figures, consultants, analysts and leading law firms.
www.biopartneringmagazine.com

Nature

For recruiters, Naturejobs is a powerful communications tool. Effective, visible, measurable and integrated, both off and online. Naturejobs has by far the highest traffic of any science job board and offers the groundbreaking Naturejobs Job Matching service that carefully matches jobs from Naturejobs to pages of relevant Nature content, essentially capturing 33 million page views per month. You can now post all your jobs online for free.
www.naturejobs.com

New Scientist

New Scientist is the world’s leading current affairs online website and weekly magazine, covering scientific and technological advances. New Scientist produces an annual Biotechnology focused feature in the magazine and online. New Scientist has been working closely with ERBI for a number of years promoting Biotechnology to professionals and students in the field. The Biotechnology feature is a must-read, it offers readers career tips, industry news and job opportunities.
www.newscientistjobs.com/insider

EBR

Published quarterly, the European Biopharmaceutical Review (EBR) provides a dedicated platform of information for the pan-European biopharmaceutical market across Europe, North America and beyond. Examining topical areas of importance, articles are written by specialists with ‘hands on’ industry experience. Established in 1997, EBR is now well-recognised for providing beneficial information to the bio-industry, thus serving as a unique forum for the European life science sector.
www.samedanltd.com/homepage/ebr.htm

BioExecutive International

BioExecutive International is dedicated to addressing the business and technology challenges facing biopharmaceutical executives. Every issue smartly covers concept to commercialisation, offering business strategies, tools and perspectives to improve business skills, execute effective business plans and become better strategic business managers, partners, developers and marketers. For more information please visit:
www.bioexecutiveintl.com

BioWorld Europe

For several years BioWorld Europe has attended the ERBI BioPartnering Exchange. Every conference since then was well-prepared and turned into an event with enriching presentations, sophisticated discussions and high profile business encounters not easily found elsewhere. The ERBI conferences fit to BioWorld Europe's profile, approach and readership. We are dedicated to the broad range of Life Science industries (incl. service providers). Our mission is platform-building across value chains and industry sectors, be it chemical, electronics, IT or materials. We support transparency for investors with peer-reviewed technical overviews and background information most of it collected on site from different countries across geographical Europe. Our authors from industry provide insights and benchmark examples for senior management. BioWorld Europe is B2B-communication.
www.bioworld-europe.com

De Facto Communications

De Facto Communications is the consultancy that life science and healthcare companies choose when they are looking for the best in strategic communications. We were established in 1989 and our reputation for informed honest, advice and effective service delivery is second to none. We focus only on life science and healthcare and, being part of the Bell Pottinger Group (the UK’s largest communications services group), we offer large consultancy reach and real international influence. We are dedicated to giving you a clear advantage in today’s increasingly competitive marketplace. Our purpose is to create a winning reputation for our clients’ companies, their products or their services. Members of our senior management team play a key role with every client, using their knowledge and expertise to ensure we deliver the best, most honest and clearest advice going. We say what we think and treat all clients with an equal degree of attention, from early stage biotechs to global pharma and leading medical device companies. We’re specialists in life science and healthcare communications, clinical trial marketing and medical education, with an in-depth knowledge of the industry issues affecting your business. Based in London, we operate internationally through our Group offices in Europe and in the US to reach the people our clients need to influence. Our medical education group, De Facto Medica, offers an expert team with deep insight into the complexities of what it takes to build a competitive reputation for a drug amongst the medical community. Their track record of success is based on their knowledge, their influence and client-centred strategic advice, spanning all high profile therapeutic areas. Our client handling team has background experience in PR, marketing, journalism, medical writing, medical education, scientific research, conference planning, digital media, business management and business development. Contact us now for an insightful discussion about your communications needs.
www.defacto.com